NDC 57884-3251-01 - Bupivacaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 57884-3251
- Requested NDC
- 57884-3251-01
- Package NDCs from labels
- 57884-3251-1, 57884-3251-01
- Manufacturer
- Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site)
- Effective date
- 2024-07-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bupivacaine | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site) | 2024-07-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57884-3251-1 | Bupivacaine | 10 mL in 1 VIAL | INJECTION, SUSPENSION, LIPOSOMAL | 10 | 4 | |
| 57884-3251-1 | Bupivacaine | 10 in 1 CARTON | INJECTION, SUSPENSION, LIPOSOMAL | 10 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 57884-3251 | BUPIVACAINE INJECTION, SUSPENSION, LIPOSOMAL [JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.] | 4 | Current NDC, 2 package rows | 20240711_0af296bb-1599-4b35-b66b-994924d3e898.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZYNRELEF | BUPIVACAINE AND MELOXICAM | Heron Therapeutics, Inc. | dab484a7-9353-43ba-9e74-7fab910c712b | 2026-04-20 | Boxed warning, Warnings, Adverse reactions | Y8335394RO |
| EXPAREL | BUPIVACAINE | Pacira Pharmaceuticals, Inc. | bb5a9e59-0f51-11df-8a39-0800200c9a66 | 2025-12-12 | Warnings, Adverse reactions | 1191508 1745061 Y8335394RO |
| Bupivacaine | BUPIVACAINE | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 0af296bb-1599-4b35-b66b-994924d3e898 | 2024-07-09 | Warnings, Adverse reactions | ANDA214348 57884-3251-1 57884-3252-1 57884-3252 57884-3251 57884325101 1191508 1745061 1c5d9dbb-0d16-6893-e063-6394a90ad989 0af296bb-1599-4b35-b66b-994924d3e898 Y8335394RO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.